Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/08/2013US8552004 Chemical compounds
10/08/2013US8552001 Sulfoxide derivatives for the treatment of tumors
10/08/2013US8552000 Therapeutic agent for senile dementia
10/08/2013US8551999 Heterocyclic compound and pharmaceutical composition thereof
10/08/2013US8551998 Delta opioid receptor agonist compounds
10/08/2013US8551997 Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
10/08/2013US8551996 Compounds, compositions, methods of synthesis, and methods of treatment
10/08/2013US8551995 Kinase inhibitor compounds
10/08/2013US8551993 Phenoxy acetic acids as PPAR delta activators
10/08/2013US8551992 Aminooxazole inhibitors of cyclin dependent kinases
10/08/2013US8551991 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
10/08/2013US8551990 Anxiolytic compounds
10/08/2013US8551989 Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof
10/08/2013US8551988 Benzimidazole derivatives: preparation and pharmaceutical applications
10/08/2013US8551987 Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate
10/08/2013US8551986 Treatment of sequelae of psychiatric disorders
10/08/2013US8551985 Carbinol derivatives having heterocyclic linker
10/08/2013US8551984 Aminopyrimidines as SYK inhibitors
10/08/2013US8551983 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/08/2013US8551982 Benzodioxane inhibitors of leukotriene production
10/08/2013US8551981 Furo[3,2-d]pyrimidine compounds
10/08/2013US8551980 Substituted triazolopyridines
10/08/2013US8551979 Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic
10/08/2013US8551978 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
10/08/2013US8551977 Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
10/08/2013US8551976 Prochelators for inhibiting metal-promoted oxidative stress
10/08/2013US8551975 Hyaluronic acid in soft gel form
10/08/2013US8551974 Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
10/08/2013US8551973 Nucleoside analogs
10/08/2013US8551972 Agonists of A2A adenosine receptors for treating recurrent tumor growth
10/08/2013US8551967 Formulations with anti-tumour action
10/08/2013US8551966 Chemical compounds
10/08/2013US8551965 Anti-viral pyrimidine nucleoside analogues
10/08/2013US8551964 Hsp90 inhibitors with modified toxicity
10/08/2013US8551963 Imidazolothiazole compounds and methods of use thereof
10/08/2013US8551962 High dosage doramectin formulation
10/08/2013US8551960 Uses of D-mannopyranose derivatives activating angiogenesis
10/08/2013US8551959 Glycolipid and use thereof
10/08/2013US8551958 Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug
10/08/2013US8551957 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate
10/08/2013US8551953 Treatment of T-cell mediated diseases
10/08/2013US8551951 Pharmaceutical preparations and methods for inhibiting tumors
10/08/2013US8551950 Method of treatment or prophylaxis of inflammatory pain
10/08/2013US8551916 Method for preparation of aqueous emulsion using interfacially active organic compound as emulsifying agent
10/08/2013US8551914 Pesticidal compositions
10/08/2013US8551699 PCA3, PCA3 genes, and methods of use
10/08/2013US8551530 Nanoparticle isoflavone compositions and methods of making and using the same
10/08/2013US8551529 Composition for the production of tablets, and method for the production of said composition
10/08/2013US8551523 Sustained release aminopyridine composition
10/08/2013US8551522 Sustained-release formulation
10/08/2013US8551521 Stable pharmaceutical composition and methods of using same
10/08/2013US8551520 Controlled release hydrocodone
10/08/2013US8551518 Lotioned wipe product to reduce adhesion of soils or exudates to the skin
10/08/2013US8551516 Administration of non-oral androgenic steroids to women
10/08/2013US8551515 Pharmacokinetics of S-adenosylmethionine formulations
10/08/2013US8551507 Terpene glycosides and their combinations as solubilizing agents
10/08/2013US8551504 Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols
10/08/2013US8551503 Topical anti-inflammatory compositions comprising O/W emulsions containing pro-penetrating glycols
10/08/2013US8551501 Chitin microparticles and their medical uses
10/08/2013US8551496 Boswellia low polar gum resin extract and its synergistic compositions
10/08/2013US8551481 Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody
10/08/2013US8551466 Hydrating compositions
10/08/2013US8551465 Composition comprising a polyol and a oil-soluble polar modified polymer
10/08/2013US8551462 Cosmetic composition and method for retarding hair growth
10/08/2013US8551460 Enhanced shine and moisture lip composition
10/08/2013US8551459 Composition comprising a polyol and a oil-soluble high carbon polar modified polymer
10/08/2013US8551458 Composition containing a hydroxylated diphenylmethane derivative
10/08/2013US8551456 Combination therapy and methods for treating bacterial biofilms
10/08/2013US8551448 Rotanone analogs: method of preparation and use
10/08/2013CA2750089C Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof
10/08/2013CA2742709C Novel 4- (azacycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
10/08/2013CA2725598C Antineoplastic combinations containing hki-272 and vinorelbine
10/08/2013CA2721222C Fungicidal active compound combinations
10/08/2013CA2710506C Use of aqueous solutions of ascorbic acid in the treatment of disorders of the eustachian tube
10/08/2013CA2706171C Fused indane compound
10/08/2013CA2703261C Antiparasitic agent for fish and method of controlling proliferation of fish parasites
10/08/2013CA2687321C Pyridyl piperidine orexin receptor antagonists
10/08/2013CA2682859C Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl)indazole for treatment of abnormal cell growth in mammals
10/08/2013CA2674358C Crystalline forms of solvated ilaprazole
10/08/2013CA2667826C Inhibitors of histone deacetylase
10/08/2013CA2653933C Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep
10/08/2013CA2647501C Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine
10/08/2013CA2640924C Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/08/2013CA2634018C Pyrimidine derivatives
10/08/2013CA2625568C Ophthalmic emulsions containing prostaglandins
10/08/2013CA2610708C Method and composition for transdermal drug delivery
10/08/2013CA2604071C Antipruritic agent for pruritus caused by multiple sclerosis
10/08/2013CA2602573C Protective agent for retinal neuronal cell containing prostaglandin f2 .alpha. derivative as active ingredient
10/08/2013CA2596178C Method for producing a drug extract that contains hydroxystilbene
10/08/2013CA2596171C Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
10/08/2013CA2595791C The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
10/08/2013CA2594582C Valnemulin salts with organic acids
10/08/2013CA2593463C [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
10/08/2013CA2587428C Manufacture process of organic compounds
10/08/2013CA2576274C Para-alkyl-substituted n-(4-hydroxy-3-methoxybenzyl)-cinnamic acid amides and the use thereof for the preparation of medicinal drugs
10/08/2013CA2570321C Inhibitors of iap
10/08/2013CA2558389C Process for the synthesis of a cxcr4 antagonist
10/08/2013CA2547459C Modulators of nik-siva complex formation for treating immune disorders
10/08/2013CA2537135C Pyrimidothiophene compounds
10/08/2013CA2531508C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
1 ... 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 ... 7860